Clinical trial
Insulin Resistance Intervention After Stroke Trial
NCT00091949 · Yale University, Other · Completed
Key facts
| NCT number | NCT00091949 |
|---|---|
| Title | Insulin Resistance Intervention After Stroke Trial |
| Official title | Insulin Resistance Intervention After Stroke (IRIS) Trial |
| Acronym | IRIS |
| Lead sponsor | Yale University, Other |
| Collaborators | National Institute of Neurological Disorders and Stroke (NINDS) NIH Takeda Pharmaceuticals North America, Inc. Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Stroke, Myocardial Infarction, Diabetes |
| Intervention type | Drug |
| Interventions | pioglitazone, placebo |
| Enrollment | 3,876 |
| Start date | Feb 1, 2005 |
| Primary completion | Nov 1, 2015 |
| Completion | Nov 1, 2015 |
| First posted | Sep 22, 2004 |
| Last update posted | Apr 27, 2020 |
| Countries | Australia, Canada, Germany, Israel, Italy, Puerto Rico, United Kingdom, United States |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: